Blood cell transplantation: Past, present and future

Hematology and Cell Therapy

Volumn 38, Issue 5, 1996, Pages 399-407

  Boiron, J M ^a   Reiffers, J ^a   Lowenthal, R M ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

bone marrow transplantation; hemopoietic growth factors; hemopoietic stem cells

Indexed keywords

CYCLOSPORIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; METHOTREXATE; PREDNISONE; STEM CELL FACTOR; VINCRISTINE;

BONE MARROW TRANSPLANTATION; FUTUROLOGY; HUMAN; PERIPHERAL BLOOD STEM CELL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0029852076     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0399-8     Document Type: Review

References (62)

1. Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood 1962; 19: 702-714
2. Malinin TI, Perry VP, Kerby CC, Dolan MF. Peripheral leukocyte infusion into lethally irradiated guinea pigs. Blood 1965; 25: 693-702.
3. Storb R, Epstein RB, Radge H, Bryant J, Donnall Thomas E. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 1967; 30: 805-811.
4. Reiffers J, Marit G, Vezon G, Cony-Makjoul P, Boiron J-M, Montastruc M, Rice A, Broustet A. Autologous blood stem cell grafing in hematological malignanices. Present status and future directions. Transfusion Sci 1992; 13: 399
5. Abrams R A, Glaubiger D, Appelbaum FR & Deisseroth AB. Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells. Blood 1980; 56: 516-520.
6. Hershko C, Ho WG, Gale RP & Cline MJ. Cure of aplastic anæmia in paroxysmal nocturnal hæmoglobinuria by marrow transfusion from identical twin: failure of peripheral-leucocyte transfusion to correct marrow aplasia. Lancet 1979; i: 945-947.
7. Goldman JM, Th'ng KH, Park DS, Spiers ASD, Lowenthal RM, Ruutu T. Collection, cryopreservation and subsequent viability of haemopoietk stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. British Journal of Haematology 1978; 40: 185-95.
8. Goldman JM, Lowenthal RM, Buskard NA, Spiers ASD, Th'ng KH, Park DS. Chronic granulocytic leukaemia - selective removal of immature granulocytic cells by leucapheresis. Series Haematologica 1975; 8: 28-40.
9. Juttner CA, To LB, Haylock DN, Branford A, Kimber RJ. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985; 61: 739
10. Reiffers J, Bernard P, David B et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 1986; 14: 312
11. Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787
12. Mariette X, Fermand JP, Brouet JC. Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplantation 1994; 14; 47
13. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; i: 640
14. Molineux G, Podja Z, Hampson IN, Lord BI, Dexter TM. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153-2158
15. Young JC, Bruno E, Luens M, Wu S, Backer M, Murray LJ. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+ Thy-1+ Lin- primitive progenitor cells. Blood 1996; 88: 1619-1631
16. Haas R, Ho AD, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte colony-stimulating factor. Exp hematol 1990; 18: 94
17. Lowenthal RM, Sullivan SA, Parker N, Marsden KA. G-CSF-primed bone marrow cells for autologous transplantation. Lancet 1996; 347: 1125
18. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996; 88: 89-97.
19. Sutherland HJ, Eaves CJ, Landsdorp PM, Phillips GL, Hogge DE. Kinetics of committed and primitive progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808
20. Rice A, Barbot C, Lacombe F et al. 5-fluorouracil permits access to primitive subpopulation of peripheral blood stem cells. Stem Cells 1993; 11; 326
21. Vesole DH, Tricot G, Jagannath S. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
22. Harousseau JL, Milpied N, Laporte JP et al. Double intensive therapy in high risk multiple myeloma. Blood 1992; 79: 2827.
23. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
24. Storb R, Graham TC, Epstein RB, Sale GE, Donnall Thomas E. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977; 50: 537-542.
25. Kessinger A, Smith D, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO. Allogeneic transplantation of blood derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastk leukemia. Bone Marrow Transplant 1989; 4: 643-646.
26. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 1992; 327: 28-35, 99-106.
27. Chang JM, Metcalf D, Gonda T & Johnson GR. Long-term exposure to retrovirally expressed granulocyte-colony-stimulatirig factor induces a non neoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J Clin Invest 1989; 84: 1488-1496.
28. Bonilla MA, Dale DC, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, Weite K, Long-term safety of treatment with recombinant human granulocyte colonystimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenia. Br J Hematol 1994; 88: 723-730.
29. Weiden PL, Sullivan K, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft versus host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529-1533.
30. Sullivan KM, Weiden PL, Storb R, et al (1989) Influence of graft versus host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73: 1720-1728.
31. Jones RJ. Allogeneic bone marrow transplantation for lymphomas. In: Bone marrow transplantation; Forman S. J., Blume K. G., Donnall Thomas E. Eds, Blackwell scientific publications, Boston, 1994; p 647-653.
32. Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders SE, Bensinger WI, Martin PJ, Storb R, Sullivan KM, Hansen JA, Thomas ED. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience. J Clin Oncol 1993; 11: 2342-2350.
33. Atkinson K, Farrell C, Chapman G, Downs K, Penny R, Biggs J. female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the bone marrow inoculum. Br J Hematol 1986; 63: 231-239
34. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Donnall Thomas E, Buckner CD. The effects of daily recombinant human granulocyte colonystimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
35. Caspar CB, Seger RA, Burger J & Gmür J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony stimulating factor. Blood 1993; 81: 2866-2871.
36. Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S. Interleukin-6 interacts with Interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitors cells. Blood 1989; 73: 1828-1835.
37. Pan L, Delmonte Jr J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422-4429.
38. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-1984.
39. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Hematol 1994; 87: 609-613.
40. Matsunaga T, Sakamaki S, Obi S, Hirayama Y, Niitsu Y. Recombinant granulocyte colony-stimulating factor can mobilize sufficient amount of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103-108.
41. Grigg AP, Roberts AW, aunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D.Optimizing dose and scheduling of Filgrastim (granulocyte colony-stimulating factor) for mobilisation and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437-4445.
42. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) anf G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
43. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
44. Azevedo WM, Aranha FJP, Gouvea JV, Vigorito AC, Marques Jr JFC, Eid KAB, Azevedo AM, Souza CA. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow transplant 1995; 16: 647-653.
45. Rambaldi A, Viero P, Buelli M, Rossi A, Bellavita P, Spinelli O, Amaru R, Micheletti M, Borleri G, Cortelazzo S, Comotti B, Barbui T. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemia. Leukemia 1996; 10: 860-865.
46. Urbano-Ispszua A, Solano C, Brunet S, et al (1996) Allogeneic peripheral blood progenitor cell transplantation: analysis of short term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 18 : 35-40
47. Rosenfeld C, Collins R, Pineiro L, Agura E, Nemunaitis J. Allogeneic blood stem cell transplantation without posttransplant colony-stumulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 1996; 14: 1314-1319.
48. Bacigalupo A, Van Lint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Valeriani A, Piaggio G, Pitto A, Benvenuto F, Figari O, De Stefano G, Caimo A, Sessarego M. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood 1996; 88: 353-357.
49. Falanga A, Marchetti M, Oldani E, Giovanelli S, Barbui T. Changes of hemostatic parameters in healthy donors administered G-CSF for peripheral blood progenitor cells (PBPC) collection. Bone Marrow Transplant 1995; 17, suppl 2: S72.
50. Etuk B, Rumi C, Salutari P, Lai M, Sica S, Leone G. RhG-CSF in healthy donors: effect on peripheral blood leukocytes. Bone Marrow Transplant 1995; 17, suppl 2: S72.
51. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deissenroth AB, Andreeff M, Champlin R. Allogeneic blood cell transplantation for refractory leukemia and lymphoma: portential advantage of blood over marrow allograft. Blood 1995: 15; 1659
52. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating-factor (G-CSF) in normal volunteers. Exp Hæmatol 1996; 24: 839-847.
53. Tjonnford GE, Steen R, Evensen SA, Thorsby E, Egeland T. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant granulocyte colony-stimulating factor. Blood 1994; 84: 1795-2801.
54. Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995; 86: 1600-1605.
55. Russell IA, Brown C, Bowen T, et al. Allogeneic blood cell transplants for hæmatological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
56. Dreger P, Viehman K, Steinman J, Eckstein V, Müller-Ruchholtz W, Löffler H, Schmilz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-I. Exp Hematol 1995; 23: 147-154.
57. Hunter AE, Cuthbert RJG, Hanky J Anderson S & Russell NH. Initial clinical experience in the use of peripheral blood stem cells for allogeneic transplantation using sibling and unrelated donors. Bone Marrow Transplant, Suppl, XXth Annual meeting of the European Group for Bone Marrow Transplantation 1994; 173: 316.
58. Arseniev L, Tischler H-J, Battmer K, Südmeier I, Casper J, Link H. Treatment of poor marrow grzft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14: 791-797.
59. Cobos E, Keung Y, Morgan D, Park CH. Successful engraftment using allogeneic peripheral blood progenitor cells in a patient with primary bone marrow graft failure. J Hematother 1995; 4: 37-40.
60. Tanaka J, Zhu X, Kobayashi S, Imai K, Hashino S, Sakurada K, Kasai M, Higa T. Potential benefit of recombinant human granulocyte colony-stimulating-factor-mobilized peripheral blood stem cells for allogeneic transplantation. Blood 1994; 84: 3595-3596.
61. Molina L, Chabannon C, Viret F, Moine A, Leger J, Nicolini F, Hollard D, Sotto J-J. Granulocyte colony-stimulating-factor-mobilized allogeneic peripheral blood stem cells for rescue graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remission. Blood, 1995; 85: 1678-1679.
62. Martelli MF, Terenzi A, Velardi A, Tabilio A, Falzetti F, Ruggieri L, Reisner Y, Aversa F. Successful engraftment of haploidentical mismatched transplants. Exp Hematol 1996; 24, 1158